Alison Slade, Shanzey Ali, Saismetha Visnukumar, Angela Hong, Devlyn Sun
{"title":"INNOVATX Global Health Case Competition 2024 – Presented by McMaster Friends of Médecins Sans Frontières","authors":"Alison Slade, Shanzey Ali, Saismetha Visnukumar, Angela Hong, Devlyn Sun","doi":"10.26685/urncst.667","DOIUrl":"https://doi.org/10.26685/urncst.667","url":null,"abstract":"","PeriodicalId":245521,"journal":{"name":"Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal","volume":"68 21","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141806720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The Effects of Alistipes-Produced GABA on the Murine Gut-Brain Serotonergic System and Major Depressive Disorder: A Research Protocol","authors":"Jia N. Vedante, Julia C. Ingarao","doi":"10.26685/urncst.611","DOIUrl":"https://doi.org/10.26685/urncst.611","url":null,"abstract":"","PeriodicalId":245521,"journal":{"name":"Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal","volume":" 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141826199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jackie Ve, Deepshikha Deepshikha, Hiba Attar, Srishti Khadilkar
{"title":"MISA Case Competition 2024","authors":"Jackie Ve, Deepshikha Deepshikha, Hiba Attar, Srishti Khadilkar","doi":"10.26685/urncst.654","DOIUrl":"https://doi.org/10.26685/urncst.654","url":null,"abstract":"","PeriodicalId":245521,"journal":{"name":"Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal","volume":" 15","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141829925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Electroencephalography and Magnetoencephalography Signatures of Ketamine Treatment in Depression: A Literature Review","authors":"Eva M. Geoghegan","doi":"10.26685/urncst.610","DOIUrl":"https://doi.org/10.26685/urncst.610","url":null,"abstract":"","PeriodicalId":245521,"journal":{"name":"Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal","volume":"125 30","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141657101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"The The Role of ICAM-1 on Immune Cells in Glioblastoma: A Literature Review","authors":"Xiaoxue Cui","doi":"10.26685/urncst.626","DOIUrl":"https://doi.org/10.26685/urncst.626","url":null,"abstract":"","PeriodicalId":245521,"journal":{"name":"Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal","volume":" 27","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141675806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Evint Leovonzko, Callixta F. Cahyaningrum, Rachmania Ulwani
Introduction: Circular RNAs (circRNAs) are increasingly recognized as key regulators of gene expression due to their unique closed-loop structure and involvement in various cellular processes. This study investigates the utilization of machine learning algorithms in predicting circRNA-disease associations. Methods: This study proposes a novel deep learning approach leveraging artificial neural networks (ANN) for circRNA classification. The methodology involves data collection from circRNA databases, k-mers counting for feature extraction, Gaussian blur implementation for data smoothing, and ANN-based model training. Results: Evaluation of the trained models based on precision, recall, and f1-score metrics shows an overall accuracy of 0.7511, with an average precision score of 0.7982, recall of 0.7511, and f1-score of 0.7637. Discussion: The results indicate that our ANN-based algorithm effectively detects and classifies circRNA datasets with considerable accuracy. Compared to the algorithm from past research, our algorithm is also shown to have less computational power. Conclusion: Comparative analysis demonstrates improved performance compared to previous algorithms, suggesting its potential for widespread implementation due to reduced computational requirements and simpler implementation.
导言:环状 RNA(circRNA)因其独特的闭环结构和参与各种细胞过程,越来越被认为是基因表达的关键调控因子。本研究探讨了如何利用机器学习算法预测 circRNA 与疾病的关联。方法:本研究提出了一种利用人工神经网络(ANN)进行 circRNA 分类的新型深度学习方法。该方法涉及从 circRNA 数据库中收集数据、用于特征提取的 k-mers 计数、用于数据平滑的高斯模糊实现以及基于 ANN 的模型训练。结果:根据精确度、召回率和 f1 分数指标对训练的模型进行评估,结果显示总体精确度为 0.7511,平均精确度为 0.7982,召回率为 0.7511,f1 分数为 0.7637。讨论结果表明,我们基于 ANN 的算法能有效地对 circRNA 数据集进行检测和分类,且准确率相当高。与过去研究的算法相比,我们的算法的计算能力也更低。结论对比分析表明,与以前的算法相比,我们的算法性能有所提高,而且由于计算要求降低、实施更简单,因此有望得到广泛应用。
{"title":"The Implementation of Deep Learning Algorithm with Gaussian Blur Data Preprocessing in Circular RNA Classification and Detection","authors":"Evint Leovonzko, Callixta F. Cahyaningrum, Rachmania Ulwani","doi":"10.26685/urncst.601","DOIUrl":"https://doi.org/10.26685/urncst.601","url":null,"abstract":"Introduction: Circular RNAs (circRNAs) are increasingly recognized as key regulators of gene expression due to their unique closed-loop structure and involvement in various cellular processes. This study investigates the utilization of machine learning algorithms in predicting circRNA-disease associations. Methods: This study proposes a novel deep learning approach leveraging artificial neural networks (ANN) for circRNA classification. The methodology involves data collection from circRNA databases, k-mers counting for feature extraction, Gaussian blur implementation for data smoothing, and ANN-based model training. Results: Evaluation of the trained models based on precision, recall, and f1-score metrics shows an overall accuracy of 0.7511, with an average precision score of 0.7982, recall of 0.7511, and f1-score of 0.7637. Discussion: The results indicate that our ANN-based algorithm effectively detects and classifies circRNA datasets with considerable accuracy. Compared to the algorithm from past research, our algorithm is also shown to have less computational power. Conclusion: Comparative analysis demonstrates improved performance compared to previous algorithms, suggesting its potential for widespread implementation due to reduced computational requirements and simpler implementation.","PeriodicalId":245521,"journal":{"name":"Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal","volume":" 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141677613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Examining Potential Biomarkers for Depression Diagnosis: A Literature Review","authors":"Gurveen K. Dhillon, Selena C. Gangaram","doi":"10.26685/urncst.621","DOIUrl":"https://doi.org/10.26685/urncst.621","url":null,"abstract":"","PeriodicalId":245521,"journal":{"name":"Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal","volume":"43 S206","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141683052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: Cancer cell adapt their metabolic activity to survive in stressful environments with limited nutrients and oxygen. To sense and respond to nutrient cues, cells rely on a “fuel gauge” protein known as AMP-activated protein kinase (AMPK). While previous work has largely focused on AMPK’s role in cell metabolism, its role in metastasis is poorly defined. Interestingly, AMPK also regulates the membrane trafficking of integrins – key proteins in cell adhesion and migration. Recent studies have also shown that circulating integrins in exosomes are predictive of metastasis. Therefore, understanding the biology of AMPK signaling on the exosomal integrin profile not only allow for better cancer treatments but also help developing a potential predictive biomarker. I hypothesize that AMPK activation alters the integrin profile of exosomes in breast and endometrial cancer. Methods: Breast and endometrial cancer cells, MDA-MB-231 and HEC-1 respectively, will be cultured in full nutrient media conditions. 48 hours before exosome harvest, the media will be changed to minimal specialized media for extracellular vesicles (EV) collection. To induce AMPK activation, cells will be treated with limiting concentrations of glucose and glutamine, or with metabolic poisons 2-deoxyglucose (2-DG) and oligomycin. Total Exosome IsolationTM (TEI) solution will be used to enrich released exosomes that will be subjected to mass spectrometry to analyze the exosomal integrin profiles. Anticipated Results: Exosomes secreted from MDA-MB-231 and HEC-1 cells are expected to contain different exosomal integrin profile in both basal and induced AMPK activation conditions. It is anticipated that integrin subunits that promote metastatic and survival signaling such as αvβ5, α6β4, α6β1, will be upregulated in exosomes following AMPK activation. This could suggest tumor cells adapting to nutrient insufficiency by AMPK activation may present a more aggressive exosomal integrin profile to support cancer progression. Discussion: Understanding how metabolic cues such as nutrient insufficiency impact integrin content of tumour-derived exosomes can help identify novel metabolic drug targets to limit pro-survival and pro-metastatic signaling in primary breast tumors. Conclusion: This study investigates how AMPK activation modulates the exosomal integrin profile in breast and endometrial cancer cells, potentially uncovering predictive biomarkers and therapeutic targets for metastatic cancers.
{"title":"Deciphering the Role of AMPK in Regulating Integrin Profile of Tumor-Derived Exosomes as a Potential Antimetastatic Strategy","authors":"Ayshin Mehrabi","doi":"10.26685/urncst.560","DOIUrl":"https://doi.org/10.26685/urncst.560","url":null,"abstract":"Introduction: Cancer cell adapt their metabolic activity to survive in stressful environments with limited nutrients and oxygen. To sense and respond to nutrient cues, cells rely on a “fuel gauge” protein known as AMP-activated protein kinase (AMPK). While previous work has largely focused on AMPK’s role in cell metabolism, its role in metastasis is poorly defined. Interestingly, AMPK also regulates the membrane trafficking of integrins – key proteins in cell adhesion and migration. Recent studies have also shown that circulating integrins in exosomes are predictive of metastasis. Therefore, understanding the biology of AMPK signaling on the exosomal integrin profile not only allow for better cancer treatments but also help developing a potential predictive biomarker. I hypothesize that AMPK activation alters the integrin profile of exosomes in breast and endometrial cancer. Methods: Breast and endometrial cancer cells, MDA-MB-231 and HEC-1 respectively, will be cultured in full nutrient media conditions. 48 hours before exosome harvest, the media will be changed to minimal specialized media for extracellular vesicles (EV) collection. To induce AMPK activation, cells will be treated with limiting concentrations of glucose and glutamine, or with metabolic poisons 2-deoxyglucose (2-DG) and oligomycin. Total Exosome IsolationTM (TEI) solution will be used to enrich released exosomes that will be subjected to mass spectrometry to analyze the exosomal integrin profiles. Anticipated Results: Exosomes secreted from MDA-MB-231 and HEC-1 cells are expected to contain different exosomal integrin profile in both basal and induced AMPK activation conditions. It is anticipated that integrin subunits that promote metastatic and survival signaling such as αvβ5, α6β4, α6β1, will be upregulated in exosomes following AMPK activation. This could suggest tumor cells adapting to nutrient insufficiency by AMPK activation may present a more aggressive exosomal integrin profile to support cancer progression. Discussion: Understanding how metabolic cues such as nutrient insufficiency impact integrin content of tumour-derived exosomes can help identify novel metabolic drug targets to limit pro-survival and pro-metastatic signaling in primary breast tumors. Conclusion: This study investigates how AMPK activation modulates the exosomal integrin profile in breast and endometrial cancer cells, potentially uncovering predictive biomarkers and therapeutic targets for metastatic cancers.","PeriodicalId":245521,"journal":{"name":"Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal","volume":"26 5‐6","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141686856","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: While Candida albicans are usually commensal and present in low density in the oral cavity of healthy individuals, an immunocompromised immune system can lead to the overgrowth of this fungal species, leading to oral microbiome “dysbiosis” and activation of immune responses. In severe cases, C. albicans overgrowth can lead to an oral infection called oropharyngeal candidiasis (OPC), which is associated with inflammation, lesions, and sores of the oral cavity. While human immunodeficiency virus (HIV) infection has been linked to an increased risk of OPC, few studies have associated OPC and C. albicans infection with subsequent risk for oral HIV acquisition. Evidence on the oral microbiome and how it can alter HIV risk is also lacking. Methods: A literature search was performed on PubMed, Google Scholar, and the University of Alberta Library Database from inception to November 2023. Results and Discussion: The risk of oral HIV transmission is low. OPC and C. albicans fungal infection can increase HIV susceptibility by activating immune responses associated with the clearance of microbial pathogens, inducing inflammation and elevations in cytokines related to HIV risk including IL-17, IL-6 and IL-1ß. Persistent C. albicans infections also promote the recruitment of T-helper 17 cells, which is a common HIV target cell, and neutrophils, which releases neutrophil proteases upon inflammation and mediates the cleavage of tight junction proteins, ultimately disrupting the oral microbiome. Conclusion: Increased immune cell recruitment to the mucosa and increased epithelial breakdown may facilitate the diffusion and access of HIV virions across the epithelium to immune target cells, suggesting that OPC and C.albicans infections has the potential to increase risk for oral HIV acquisition. Limited evidence of the relationship between C. albicans density, OPC, and oral HIV risk, warrants high-quality cross-sectional studies in the future.
介绍:虽然白色念珠菌通常是共生菌,在健康人的口腔中存在密度较低,但免疫系统受损会导致这种真菌过度生长,导致口腔微生物组 "菌群失调 "和免疫反应激活。在严重的情况下,白色念珠菌过度生长会导致口腔感染,称为口咽念珠菌病(OPC),与口腔炎症、病变和溃疡有关。虽然人类免疫缺陷病毒(HIV)感染与口咽念珠菌病的风险增加有关,但很少有研究将口咽念珠菌病和白僵菌感染与随后的口腔 HIV 感染风险联系起来。有关口腔微生物组及其如何改变 HIV 风险的证据也很缺乏。研究方法在 PubMed、Google Scholar 和阿尔伯塔大学图书馆数据库(University of Alberta Library Database)上进行了文献检索,时间从开始到 2023 年 11 月。结果与讨论:口腔传播艾滋病毒的风险很低。通过激活与清除微生物病原体相关的免疫反应、诱导炎症和与 HIV 风险相关的细胞因子(包括 IL-17、IL-6 和 IL-1ß)的升高,OPC 和白僵菌真菌感染可增加对 HIV 的易感性。持续的白念珠菌感染还会促进 Thelper 17 细胞(T-helper 17 细胞是常见的 HIV 靶细胞)和中性粒细胞的招募,中性粒细胞会在炎症时释放中性粒细胞蛋白酶,并介导紧密连接蛋白的裂解,最终破坏口腔微生物群。结论免疫细胞招募到粘膜的增加和上皮细胞破坏的增加可能会促进艾滋病毒病毒穿过上皮细胞扩散并进入免疫靶细胞,这表明 OPC 和白念珠菌感染有可能增加口腔感染艾滋病毒的风险。有关白僵菌密度、OPC 和口腔 HIV 风险之间关系的证据有限,因此今后需要进行高质量的横断面研究。
{"title":"Oropharyngeal Candidiasis, Candida Albicans Infections, and Oral Immune Mediators Associated with Oral Human Immunodeficiency Virus: A Literature Review","authors":"Cameron B.R. King","doi":"10.26685/urncst.563","DOIUrl":"https://doi.org/10.26685/urncst.563","url":null,"abstract":"Introduction: While Candida albicans are usually commensal and present in low density in the oral cavity of healthy individuals, an immunocompromised immune system can lead to the overgrowth of this fungal species, leading to oral microbiome “dysbiosis” and activation of immune responses. In severe cases, C. albicans overgrowth can lead to an oral infection called oropharyngeal candidiasis (OPC), which is associated with inflammation, lesions, and sores of the oral cavity. While human immunodeficiency virus (HIV) infection has been linked to an increased risk of OPC, few studies have associated OPC and C. albicans infection with subsequent risk for oral HIV acquisition. Evidence on the oral microbiome and how it can alter HIV risk is also lacking. Methods: A literature search was performed on PubMed, Google Scholar, and the University of Alberta Library Database from inception to November 2023. Results and Discussion: The risk of oral HIV transmission is low. OPC and C. albicans fungal infection can increase HIV susceptibility by activating immune responses associated with the clearance of microbial pathogens, inducing inflammation and elevations in cytokines related to HIV risk including IL-17, IL-6 and IL-1ß. Persistent C. albicans infections also promote the recruitment of T-helper 17 cells, which is a common HIV target cell, and neutrophils, which releases neutrophil proteases upon inflammation and mediates the cleavage of tight junction proteins, ultimately disrupting the oral microbiome. Conclusion: Increased immune cell recruitment to the mucosa and increased epithelial breakdown may facilitate the diffusion and access of HIV virions across the epithelium to immune target cells, suggesting that OPC and C.albicans infections has the potential to increase risk for oral HIV acquisition. Limited evidence of the relationship between C. albicans density, OPC, and oral HIV risk, warrants high-quality cross-sectional studies in the future.","PeriodicalId":245521,"journal":{"name":"Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal","volume":" 33","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140993449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cancer is one of the leading causes of global mortality and continues to persist as a significant healthcare burden. Patient non-responsiveness or relapse following first-line cancer treatments necessitates the development of novel treatments. Platelets are small blood cells that are essential to stop bleeding. Platelets are increasingly recognized for their roles in supporting tumorigenesis. They can aid cancer cells to evade immune cells, promote immune suppression, and release molecules that protect the stability of tumor microenvironments. Conversely, platelets can also secrete molecules that recruit leukocytes to the site of tissue injury and coordinate immune cell responses and crosstalk. Anti-platelet therapies, including aspirin, have been advocated as preventive measures in some cancers, but the long-term risks for bleeding, thrombotic events, ineffective immune responses, and overall efficacy towards cancer recovery remain uncertain. To address these gaps, this literature review reports pre-clinical studies and clinical trials from 2017-2023 that explore (1) novel molecules and pathways participating in platelet and cancer cell crosstalk, (2) overall efficacy of cancer treatment or effects on cancer cell survival, proliferation, and metastasis, and (3) safety of anti-platelet therapy. This study’s findings reveal that anti-platelet therapies have an improved benefit for the prevention and treatment of some cancers, such as colorectal, breast, prostate, or lung cancers. There has been some success using anti-platelet treatments, such as ticagrelor to inhibit P2Y12 pathway, or low molecular weight heparin. While aspirin usage was successful in some cancers, such as colorectal cancer, it was not effective in others, such as ovarian cancer. Finally, the safety of using anti-platelet medications was explored; these medications may increase the risk of bleeding and other side effects, even if they have demonstrated promise in lowering the risk of cancer and increasing patient survival. Overall, this review highlights the complex interactions between platelets and different cancers, with considerations for cancer treatment efficacy and safety.
{"title":"Investigating Therapeutic Potential of Targeting Platelets in Cancer Treatment: A Literature Review","authors":"Bahar Taghizadeh","doi":"10.26685/urncst.574","DOIUrl":"https://doi.org/10.26685/urncst.574","url":null,"abstract":"Cancer is one of the leading causes of global mortality and continues to persist as a significant healthcare burden. Patient non-responsiveness or relapse following first-line cancer treatments necessitates the development of novel treatments. Platelets are small blood cells that are essential to stop bleeding. Platelets are increasingly recognized for their roles in supporting tumorigenesis. They can aid cancer cells to evade immune cells, promote immune suppression, and release molecules that protect the stability of tumor microenvironments. Conversely, platelets can also secrete molecules that recruit leukocytes to the site of tissue injury and coordinate immune cell responses and crosstalk. Anti-platelet therapies, including aspirin, have been advocated as preventive measures in some cancers, but the long-term risks for bleeding, thrombotic events, ineffective immune responses, and overall efficacy towards cancer recovery remain uncertain. To address these gaps, this literature review reports pre-clinical studies and clinical trials from 2017-2023 that explore (1) novel molecules and pathways participating in platelet and cancer cell crosstalk, (2) overall efficacy of cancer treatment or effects on cancer cell survival, proliferation, and metastasis, and (3) safety of anti-platelet therapy. This study’s findings reveal that anti-platelet therapies have an improved benefit for the prevention and treatment of some cancers, such as colorectal, breast, prostate, or lung cancers. There has been some success using anti-platelet treatments, such as ticagrelor to inhibit P2Y12 pathway, or low molecular weight heparin. While aspirin usage was successful in some cancers, such as colorectal cancer, it was not effective in others, such as ovarian cancer. Finally, the safety of using anti-platelet medications was explored; these medications may increase the risk of bleeding and other side effects, even if they have demonstrated promise in lowering the risk of cancer and increasing patient survival. Overall, this review highlights the complex interactions between platelets and different cancers, with considerations for cancer treatment efficacy and safety.","PeriodicalId":245521,"journal":{"name":"Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal","volume":"18 S4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141009198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}